Arimoclomol & Ipique Developers To Make Their Case For EU Approval
Orphazyme & Rotterdam Biologics Are Scheduled To Present Before The EMA This Week
The sponsors of two investigational drugs that have previously experienced key regulatory setbacks are set to give oral explanations to the European Medicines Agency about why they believe their products should be approved in the EU.
